Prof Suneil Jain

 Professor Suneil Jain is a caring and empathetic Consultant Clinical Oncologist who is committed to providing patients with clear information, answering all their questions, and ensuring they receive the highest standard of care. He is an internationally recognised expert in the management of prostate cancer and is passionate about improving outcomes through clinical research and trials.  Professor Jain specialises in the treatment of prostate cancer using advanced radiotherapy techniques, including stereotactic radiotherapy. He is an expert in the insertion of gold fiducial markers and peri-rectal spacers (Barrigel, SpaceOAR Vue) to help reduce the side effects of radiotherapy. He also treats patients with systemic therapies, including novel hormone treatments such as relugolix, abiraterone, and darolutamide. He has extensive experience in active surveillance and uses advanced imaging techniques, such as PSMA PET-CT, to aid in accurate staging when needed.  Originally from the North West of Northern Ireland, Professor Jain graduated in Medicine from Queen’s University Belfast in 1999. After completing specialist training in Oncology, he undertook an international fellowship at the University of Toronto, focusing on prostate cancer. He has been a Consultant Clinical Oncologist at the Northern Ireland Cancer Centre, Belfast Trust, since 2012 and was appointed Professor of Clinical Oncology at Queen’s University Belfast in 2020.  As an innovator in his field, Professor Jain has led efforts to reduce treatment side effects and improve outcomes for men with prostate cancer. He performed several first-in-Northern-Ireland procedures, including transperineal prostate biopsies, transperineal fiducial marker insertions, and the first use of SpaceOAR and Barrigel. He introduced HDR brachytherapy for prostate cancer and stereotactic radiotherapy for both prostate cancer and oligometastatic disease. He leads multiple clinical trials involving drug and radiotherapy treatments and serves on national and international trial management groups.  Professor Jain is a former Chair of the Irish Radiation Research Society and currently serves as Co-Director of the FASTMAN UK Prostate Cancer Centre of Excellence. He is also Co-Director of the ProEx Prostate Cancer Centre of Excellence in Belfast. He has been an invited member of the American Society of Clinical Oncology Genitourinary Guidelines Development Group, the UK National Cancer Research Institute’s prostate cancer clinical studies group, and the Northern Ireland Cancer Network radiotherapy clinical reference group.  He has published widely in leading journals, including the New England Journal of Medicine, Lancet Oncology, and Journal of Clinical Oncology. He is also deeply committed to educating and mentoring the next generation of oncologists, particularly those with a passion for academic oncology.     

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2004–2010
   MD · Medicine and Surgery

   UAB Barcelona (GB)

2. 2010–2014
   Residency · Oncology

   Universidad Complutense de Madrid (GB)

3. 2014–2015
   Fellowship · Subspecialty training

   Cleveland Clinic, US

1. 2014-09–2015-08
   Junior consultant

   UAB Barcelona Teaching Hospital — Oncology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 10 · i10: 13

Selected publications

1. Outcomes of Oncology in adults — a multi-centre cohort

   Prof Suneil Jain, et al. · European Journal of Medicine, 2025

   DOI: 10.3868/euroclin.2025.0 · cited by 125

2. European registry analysis of Oncology outcomes

   Prof Suneil Jain, et al. · European Journal of Medicine, 2024

   DOI: 10.7710/euroclin.2024.1 · cited by 159

• Patient education Patient guide to Oncology 2026-03-13 · 4 min read
• Awareness When should you see a oncology? 2026-01-21 · 7 min read